Our top 10 lists tell you where a brand ranks; these reviews tell you why. Think of each one as the full scorecard behind a single line on a ranking — every factor from our rubric, graded in the open, with the evidence attached. If a provider lost points for a membership fee that only appears at checkout or a refund policy that quietly excludes opened vials, the review is where that gets documented.
All eleven scorecards run through an identical checklist, in an identical order, so you can put any two side by side: the verified monthly price at each dose tier, whether your bill grows as your dose does, which compounding pharmacy actually fills the orders, what the "online visit" consists of, which states the program ships to, who gets screened out at intake, and — the question support teams dread — exactly how many steps it takes to cancel. Where a brand publishes a claim we could not confirm from any independent source, the review says "unverified" instead of repeating it.
The number at the top of each review is a 1–10 editorial score assembled from documented, public information: the provider's own pricing and policy pages, state coverage disclosures, Better Business Bureau records, and verified-review platforms. It follows the weighted rubric published on our How We Rank page, where pricing transparency counts for more than anything else. What the score is not: a product test. We have not taken these medications and will not pretend we have — a distinction most affiliate review sites blur and we refuse to.
Money, since you should ask: several of the brands below pay us a commission when a reader signs up through our links, and that revenue is why the site exists. What it buys them is presence in our coverage — not points. Scores are computed the same way for partners and non-partners, negative findings stay published no matter who pays, and the disclosure banner above appears on every review. The complete picture is in our advertising disclosure.
Context for the prices you are about to see: brand-name pens still run four figures a month at U.S. retail without insurance, which is precisely why telehealth programs selling compounded semaglutide and tirzepatide at $89 to $399 a month multiplied so quickly. Cheap does not automatically mean shady — but the gap between those numbers is where every trick in this industry lives, from 503A pharmacies with thin track records to auto-renewals that outlast the prescriptions. The reviews below are built to catch exactly those tricks before your card does.